Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine for prevention of efavirenz-related neuropsychiatric adverse effects
IRCT201103106026N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyproheptadine in human immunodeficiency virus infection (HIV), sponsored by Tehran University of Medical Sciences. Started Nov 2011; status: completed.
02
Drugs
cyproheptadine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on IRCT201103106026N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201103106026N1.